The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson's disease.

Rationale: Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson's disease (PD) and other Lewy-body disorders. Spatial covariance analysis of [18F]-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG-PET) data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it to the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we study the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG-PET scans of 21 patients with polysomnographically-confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG-PET scans of 44 controls and 38 de novo, treatment-naive PD patients. Of these 38 PD patients, 24 had probable RBD according to the Mayo Sleep Questionnaire. Neuropsychological evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom sixteen also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in cerebellum, brainstem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in middle cingulate, temporal, occipital and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared to controls (P<0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern expression was higher in PD-MCI patients, compared to PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r=0.94, P<0.0001). Conclusion: In conclusion, our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the two patterns increases with disease severity.

Publication type: 
Articolo
Author or Creator: 
Meles, Sanne Katherina
Renken, Remco J
Janzen, Annette H O
Vadasz, David
Pagani, Marco
Arnaldi, Dario
Morbelli, Silvia
Nobili, Flavio
Mayer, Geert
Leenders, Klaus L
Oertel, Wolfgang H O
Publisher: 
Society of Nuclear Medicine., [New York], Stati Uniti d'America
Source: 
NM, Journal of nuclear medicine (2018). doi:10.2967/jnumed.117.202242
Date: 
2018
Resource Identifier: 
http://www.cnr.it/prodotto/i/384850
https://dx.doi.org/10.2967/jnumed.117.202242
info:doi:10.2967/jnumed.117.202242
Language: 
Eng
ISTC Author: 
Marco Pagani's picture
Real name: